Static magnetic field exposure reproduces cellular effects of the Parkinson's disease drug candidate ZM241385.
Wang Z, Che PL, Du J, Ha B, Yarema KJ. · 2010
View Original AbstractStatic magnetic fields mimicked a Parkinson's drug's effects on brain cells, suggesting magnetic therapy potential while confirming fields have real biological impact.
Plain English Summary
Researchers exposed rat brain cells to static magnetic fields and found they produced the same cellular changes as a promising Parkinson's disease drug called ZM241385. The magnetic fields altered calcium levels, energy production, and other cellular processes in ways that could potentially help treat Parkinson's disease. This suggests magnetic field therapy might offer a non-invasive treatment approach for neurological disorders.
Why This Matters
This research opens an intriguing window into magnetic fields as potential therapeutic tools rather than just health concerns. The fact that static magnetic fields can mimic the cellular effects of a Parkinson's drug candidate suggests these fields have genuine biological activity at the cellular level. What makes this particularly significant is that the researchers used moderate-strength fields (0.1 to 1 Tesla) - comparable to those used in some magnetic therapy devices, though much stronger than typical household exposures which measure in microtesla. While this study used laboratory cell cultures rather than living organisms, it demonstrates that magnetic fields can produce specific, measurable changes in brain cells. The reality is that if magnetic fields can therapeutically alter cellular function, they can also potentially cause harm under different circumstances or exposure conditions.
Exposure Information
Specific exposure levels were not quantified in this study.
Study Details
The current paper investigated SMF by focusing on the adenosine A2A receptor (A2AR) in the PC12 rat adrenal pheochromocytoma cell line that displays metabolic features of Parkinson's disease (PD).
SMF reproduced several responses elicited by ZM241385, a selective A2AR antagonist, in PC12 cells in...
When measured against multiple endpoints, SMF elicited qualitatively similar responses as ZM241385, a PD drug candidate. Provided that the in vitro results presented in this paper apply in vivo, SMF holds promise as an intriguing non-invasive approach to treat PD and potentially other neurological disorders.
Show BibTeX
@article{z_2010_static_magnetic_field_exposure_1779,
author = {Wang Z and Che PL and Du J and Ha B and Yarema KJ.},
title = {Static magnetic field exposure reproduces cellular effects of the Parkinson's disease drug candidate ZM241385.},
year = {2010},
url = {https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0013883},
}